ASKBIO

AskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic and complex disorders. Learn more about our gene therapy technology and current clinical trials... AskBio is headquartered in Research Triangle Park, North Carolina, a thriving biotechnology hub with nearly 600 life science companies. Research and development facilities are located in Philadelphia, Pennsylvania; Upper Arlington, Ohio; and globally in Edinburgh, Scotland; Heidelberg, Germany; and Paris, France. Gene therapy manufacturing facilities are located in San Sebastian, Spain... Our technology and AAV therapeutic assets have been acquired or licensed by leading pharmaceutical companies such as Bayer, Pfizer, Takeda and Novartis. This validates our gene therapy development leadership and is even more significant considering that the first two FDA-approved gene therapies are based on the research of our founders and AskBio's current technology.

Also known as: Asklepios BioPharmaceutical, Asklepios BioPharmaceutical, Inc.

Primary location: Park United States